Skip to main content

Degenerative Conditions of the Lumbar Spine

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Globus Medical
Globus MedicalAUDUBON, PA
1 program
AttraX PuttyN/A1 trial
Active Trials
NCT02250248Completed45Est. May 2021
NuVasive
NuVasiveCA - San Diego
1 program
AttraX PuttyN/A
Spinal Simplicity
Spinal SimplicityKS - Overland Park
1 program
Minuteman G5 DeviceN/A1 trial
Active Trials
NCT06355791Recruiting150Est. Dec 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Spinal SimplicityMinuteman G5 Device
Globus MedicalAttraX Putty

Clinical Trials (2)

Total enrollment: 195 patients across 2 trials

NCT06355791Spinal SimplicityMinuteman G5 Device

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

Start: May 2024Est. completion: Dec 2030150 patients
N/ARecruiting

AttraX® Putty vs. Autograft in XLIF®

Start: Dec 2014Est. completion: May 202145 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 195 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.